We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





BioPerfectus Showcases SAW-48 Automated Nucleic Acid Workstation

By LabMedica International staff writers
Posted on 23 May 2023
Print article
Image: Bioperfectus is a bronze sponsor of the 2023 WordLab-EuroMedLab Congress (Photo courtesy of Bioperfectus)
Image: Bioperfectus is a bronze sponsor of the 2023 WordLab-EuroMedLab Congress (Photo courtesy of Bioperfectus)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) is highlighting its comprehensive range of laboratory solutions that are designed to address the diagnostic needs of laboratories at this year's WorldLab-EuroMedLab. As a bronze sponsor of the Congress, Bioperfectus is welcoming visitors at the La Nuvola Convention Center in Rome to its booth, ready to present its full range of diagnostic solutions to enhance the efficiency and quality of healthcare services.

Bioperfectus is showcasing the SAW-48 automated nucleic acid extraction workstation, an in-vitro diagnostic medical device that combines sample loading, nucleic acid purification, and PCR setup functions (PCR master mix preparation and nucleic acid pipetting) into one instrument. The SAW-48 offers the same basic functions as the SAW-96 but in a smaller and lighter form factor. Also on display at the booth is the SSNP-2000B nucleic acid extraction system, a laboratory medical device that integrates state-of-the-art technologies to enable automatic nucleic acid extraction of up to 32 samples at a time.

In addition, Bioperfectus is highlighting the SSNP-A6 nucleic acid extraction system, an in-vitro diagnostic medical device that leverages cutting-edge mechanical, electronic, and software technologies to facilitate the automated extraction of nucleic acids from samples. Visitors to the Bioperfectus booth will have the opportunity to experience the STC-96A Plus Real-Time PCR system, a highly flexible, efficient, and reliable instrument that marks a breakthrough in real-time PCR analysis of gene expression and genetic variation. The STC-96A allows users to perform two different PCR assays on a single instrument with separate-controlled programs, offering enhanced versatility. BioPerfectus is also presenting its diagnostic solutions for the detection of respiratory and gastrointestinal infections, cervical cancer screening, as well as vector-borne and zoonotic diseases.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.

New
Gold Member
LEISHMANIA Test
LEISHMANIA ELISA
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
RFID Tag
AD-302 M730
New
Basophil Activation Test
Flow CAST Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: A coronal MRI section shows a high-intensity focused ultrasound lesion in the left thalamus of the brain (Photo courtesy of UT Southwestern Medical Center)

Newly Identified Stroke Biomarkers Pave Way for Blood Tests to Quickly Diagnose Brain Injuries

Each year, nearly 800,000 individuals in the U.S. experience a stroke, which occurs when blood flow to specific areas of the brain is insufficient, causing brain cells to die due to a lack of oxygen.... Read more

Immunology

view channel
Image: New insights into preterm infant immunity could inform care (Photo courtesy of 123RF)

New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood

Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more

Pathology

view channel
Image: As tumor cells flow through these microfluidic chambers, they are subjected to increasing shear stress and sorted based on their adhesion strength (Photo courtesy of UC San Diego)

Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread

Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.